Keratotic Nodular Size
6
0
0
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (6)
Effect of Thymoquinone Extracted From Nigella Sativa in the Treatment of Arsenical Keratosis
Effect of the Compound Extracted From Azadirachta Indica Leaves in the Treatment of Arsenical Keratosis
Use of Topical Solasodine of Solanum Melongena Peel Origin in the Treatment of Palmar Arsenic Keratosis
Effect of Pumpkin Seeds in the Treatment of Moderate to Severe Palmar Arsenical Keratosis
Identification of Compound From Brinjal Peel Extract in the Treatment of Palmar Arsenical Keratosis and Bowen's Disease
Effects of Antimicrobials on the Altered Skin Flora in Arsenical Keratosis